Members |
targetComponentId |
Tic disorder unspecified |
Tic (finding) |
Tic disorder unspecified |
Tic (finding) |
Ticarcillin 3g/clavulanic acid 100mg powder for injection solution vial |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ticarcillin disodium 1g powder for injection solution vial |
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ticarcillin disodium 20g powder for injection solution vial |
Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ticarcillin disodium 3g powder for injection solution vial |
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Tiludronate disodium |
Product containing tiludronic acid (medicinal product) |
Time since symptom started NOS |
Symptom findings in relation to start time |
Time since symptom started NOS |
Symptom findings in relation to start time |
Time symptom lasts NOS |
Symptom findings in relation to time lasts (finding) |
Time symptom lasts NOS |
Time symptom lasts |
Time zone syndrome |
Jet lag (finding) |
Timed unsupported steady stand test |
Timed unsupported steady stand time |
Timolol maleate 0.25% ophthalmic solution |
Timolol (as timolol maleate) 2.5 mg/mL eye drops |
Timolol maleate 0.5% |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Timolol maleate 0.5% ophthalmic solution |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Timolol maleate+bendroflumethiazide |
Product containing bendroflumethiazide and timolol (medicinal product) |
Tinnitus symptom NOS |
Tinnitus |
Tinnitus symptom NOS |
Tinnitus |
Tiotropium 18microgram inhalation powder capsule |
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
Tiotropium 18microgram inhalation powder capsule with device |
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
Tis (0): Carcinoma in situ (limited to fallopian tube mucosa) |
American Joint Committee on Cancer cTis (qualifier value) |
Tis (0): Carcinoma in situ (vagina) |
American Joint Committee on Cancer cTis (qualifier value) |
Tis category |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: Carcinoma in situ ("flat tumor" of urinary bladder) |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: Carcinoma in situ (endometrium/uterine cervix) |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: Carcinoma in situ |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: Epithelium only (carcinoma in situ, no invasion) |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: Intratubular germ cell neoplasia (carcinoma in situ, testis) |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: Tumor invades lamina propria (gastrointestinal tumor) |
American Joint Committee on Cancer cTis(LAMN) (qualifier value) |
Tis: Tumor invades muscularis mucosae (colon/rectum) |
American Joint Committee on Cancer cTis (qualifier value) |
Tissue culture for chromosome analysis, more complex procedure with special extra counts |
Chromosome analysis |
Tissue cytology NOS |
Cytologic test |
Tissue cytology NOS |
Cytologic test |
Tissue disruption operation NOS |
Tissue disruption operation |
Tissue disruption operation NOS |
Tissue disruption operation |
Tissue injection for local action |
Injection |
Tissue injection for local action NOS |
Injection |
Tissue injection for local action NOS |
Injection |
Tissue kallikrein |
Kininogen |
Tissue processing technique, complex, embed, cut and stain, per autopsy |
Tissue processing technique |
Tissue processing technique, complex, embed, cut and stain, per surgical specimen |
Tissue processing technique |
Titanium dioxide 20% paste |
Product containing only titanium dioxide (medicinal product) |
Tobacco consumption NOS |
Tobacco use and exposure |
Tobacco consumption NOS |
Tobacco use and exposure |
Tobacco dependence with current use |
Tobacco dependence syndrome |
Tobacco processor NOS |
Tobacco processor |
Tobacco processor NOS |
Tobacco processor |
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Tobramycin 1.2g powder for injection solution vial |
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
Tobramycin 1.2mg/mL injection |
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
Tobramycin 300mg/5mL nebulizer solution |
Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
Tobramycin 60mg/mL solution |
Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
Tocilizumab 20mg/mL conventional release solution for injection |
Tocilizumab only product in parenteral dose form |
Tocilizumab 20mg/mL solution for intravenous infusion |
Tocilizumab only product in parenteral dose form |
Tocopherol |
Vitamin E and/or vitamin E derivative (substance) |
Toe X-ray |
Plain X-ray of toe (procedure) |
Toe X-ray |
Plain X-ray of toe (procedure) |
Toe X-ray |
Plain X-ray of toe (procedure) |
Toe flap |
Flap (substance) |
Tolnaftate+chlorhexidine hydrochloride |
Product containing chlorhexidine and tolnaftate (medicinal product) |
Tolterodine 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine L-tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine L-tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine L-tartrate 4mg prolonged-release oral capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine tartrate 2mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine tartrate 2mg prolonged-release oral capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Toluene diisocyanate specific extract |
Toluene-2-4-diisocyanate |
Tomato - dietary |
Tomato (substance) |
Tomilol |
Timolol (substance) |
Tomography - NOS |
Tomographic imaging procedure (procedure) |
Tomography - NOS |
Tomographic imaging procedure (procedure) |
Tongue diseases NOS |
Disorder of tongue (disorder) |
Tongue diseases NOS |
Disorder of tongue (disorder) |
Tongue flap |
Flap (substance) |
Tonic seizures, non-refractory |
Tonic epileptic seizure (finding) |
Tonic-clonic epilepsy |
Epilepsy |
Tonic-clonic seizure, non-refractory |
Tonic-clonic epileptic seizure |
Tonsil (& peritonsillar region) |
Palatine tonsillar structure |
Tonsil/adenoid operation NOS |
Operations on tonsil and adenoid |
Tonsil/adenoid operation NOS |
Operations on tonsil and adenoid |
Tooth and gingiva operations NOS |
Tooth and gingiva operations |
Tooth and gingiva operations NOS |
Tooth and gingiva operations |
Tooth attrition |
Excessive attrition of teeth |
Tooth decalcification |
Incipient enamel caries |
Tooth eruption disturbances NOS |
Tooth eruption disorder (disorder) |
Tooth removal NOS |
Tooth extraction |
Tooth removal NOS |
Tooth extraction |
Tooth restoration NOS |
Restoration of tooth (procedure) |
Tooth restoration NOS |
Restoration of tooth (procedure) |
Tooth symptom NOS |
Tooth symptoms |
Tooth symptom NOS |
Tooth symptoms |
Top manager - business NOS |
Top manager - business |
Top manager - business NOS |
Top manager - business |
Topical anesthesia for procedure on eye |
Administration of anesthesia (procedure) |
Topical compound dexamethasone preparation allergy |
Allergy to dexamethasone |
Topical compound hydrocortisone preparation allergy |
Allergy to hydrocortisone (finding) |
Topical corticosteroid, group I |
Glucocorticoid (substance) |
Topical corticosteroid, group II |
Glucocorticoid (substance) |
Topical corticosteroid, group III |
Glucocorticoid (substance) |